Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men

Journal of Urology

Volumn 160, Issue 5, 1998, Pages 1734-1738

  Smith, Deborah S ^a   Carvalhal, Gustavo F ^a   Mager, Douglas E ^a   Bullock, Arnold D ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blacks; Prostate; Prostate specific antigen; Prostatic neoplasms; Whites

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CAUCASIAN; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE;

EID: 0012061299     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62395-4     Document Type: Article

References (20)

1. Arcangeli, C. G., Ornstein, D. K., Keetch, D. W. and Andriole, G. L.: Prostate-specific antigen as a screening test for prostate cancer. The United States experience. Urol. Clin. N. Amer., 24: 299, 1997.
2. Smith, D. S., Bullock, A. D. and Catalona, W. J.: Racial differences in operating characteristics of prostate cancer screening tests. J. Urol., 158: 1861, 1997.
3. Parker, S. L., Davis, K. J., Wingo, P. A., Ries, L. A. G. and Heath, C. W., Jr.: Cancer statistics by race and ethnicity. CA, 48: 31, 1998.
4. Merril, R. M. and Brawley, O. W.: Prostate cancer incidence and mortality rates among white and black men. Epidemiology, 8: 126, 1997.
5. Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McLeod, D. G. and Moul, J. W.: Age-specific reference ranges for prostate-specific antigen in black men. New Engl. J. Med., 335: 304, 1996.
6. Colberg, J. W., Smith, D. S. and Catalona, W. J.: Prevalence and pathological extent of prostate cancer in men with prostate specific antigen levels of 2.9 to 4.0 ng./ml. J. Urol., 149: 507, 1993.
7. Gann, P. H., Hennekens, C. H. and Stampfer, M. J.: A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. J.A.M.A., 273: 289, 1995.
8. Catalona, W. J., Smith, D. S. and Ornstein, D. K.: Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng./ml. and benign prostate examination. Enhancement of specificity with free PSA measurements. J.A.M.A., 277: 1452, 1997.
9. Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G., Ratliff, T. L. and Nadler, R. B.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A., 247: 1214, 1995.
10. Scheckowitz, E. M. and Resnick, M. I.: Imaging of the prostate. Benign prostatic hyperplasia. Urol. Clin. N. Amer., 22: 321, 1995.
11. Rosenthal, D. S.: Changing trends. CA, 48: 3, 1998.
12. Wingo, P. A., Landis, S. and Ries, L. A.: An adjustment to the 1997 estimate for new prostate cancer cases. CA, 47: 239, 1997.
13. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1998. CA, 48: 6, 1998.
14. Mebane, C., Gibbs, T. and Horm, J.: Current status of prostate cancer in North American black males. J. Natl. Med. Assn., 82: 782, 1990.
15. Powell, I. J.: Prostate cancer and African-American men. Oncology, 11: 599, 1997.
16. Wu, A. H., Whittemore, A. S., Kolonel, L. N., John, E. M., Gallagher, R. P., West, D. W., Hankin, J., Teh, C. Z., Dreon, D. M. and Paffenbarger, R. S., Jr.: Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol. Biomark. Prev., 4: 735, 1995.
17. Mettlin, C. J., Murphy, G. P., Cunningham, M. P. and Menck, H. R.: The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer, 80: 1261, 1997.
18. Smith, D. S., Bullock, A. D., Catalona, W. J. and Herschman, J. D.: Racial differences in a prostate cancer screening study. J. Urol., 156: 1366, 1996.
19. Optenberg, S. A., Thompson, I. M., Friedrichs, P., Wojcik, B., Stein, C. R. and Kramer, B.: Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. J.A.M.A., 274: 1599, 1995.
20. Littrup, P. J.: Future benefits and cost-effectiveness of prostate carcinoma screening. Cancer, 80: 1864, 1997.